AstraZeneca begins COVID-19 dual-use antibody drug trial in UK

UK-headquartered biopharmaceutical giant AstraZeneca on Tuesday announced the start of clinical trials for an antibody drug which offers dual hope to treat and prevent COVID-19. The drug known as AZD7442 has the potential to be given as a preventative option for people exposed to the Coronavirus and to treat and prevent disease...